Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MDA (Medical Devices Agency) eyes Boston stent fractures

This article was originally published in Clinica

Executive Summary

The UK Medical Devices Agency (MDA) has warned of the potential radial fracture of coronary stents made by Boston Scientific Scimed, after the company recently reported that there had been nine such incidents since March 2000. Last week's Device Alert affects five NIRoyal (NIR) products, namely the NIR stent, the NIR premounted stent system (PSS), the NIR Advance PSS, the NIR Elite Monorail PSS and the NIR Elite over-the-wire PSS. Around 200,000 Boston NIR stents have been distributed worldwide since they were first marketed in 1998.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT068008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel